Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
This episode will review the practical use of Next Generation Sequencing in a community oncology clinical setting. With multi-gene cancer Hotspot NGS testing now routinely available for clinical use , we will discuss the most clinically relevant aspect of pathology and NGS.
Key Opinion Leader:
Dr. Brandon Sheffield, Antaomic and Molecular Pathologist
Medical Director of Advanced Diagnostics and Physician Lead of Research
William Osler Health Systems, Brampton, Ontario, Canada.
Host: Dr. Shaqil Kassam, Medical Oncologist Stronach Regional Cancer Centre
Medical Director of Research Southake Health Centre
Newmarket, Ontario, Canada
POD Cast Legend:
Introductions: 0:00 mins
Pathology 101 - 2:30 mins
PDL1 TPS/CPS - 10:30 mins
NGS – 25:20 mins
